Israel Ogbole, CEO and Co-Founder of Zymtrace (right), with Joel Höner, CTO and Co-Founder of Zymtrace (left). The company ...
To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results